Listed pharmas significantly cut advertising expenses

Pharmaceutical companies were observed to significantly reduce advertising expenses as part of a strategy to control SG&A(selling, general and administrative) expenses this year.

Hanmi Pharm, in particular, was surveyed to reduce surprising KRW 12.6 billion of advertising expenses this year unlike the 1^st half of the 2016.

Yakup Shinmoon(www.yakup.com) analyzed KOSPI and KOSDAQ listed pharmac...